GLS and neoplasm: Multiple oncogenes are involved in reprogramming glutamine metabolism to drive fast proliferation in tumor cells, including MYC which is known to upregulate the glutamine transporter SLC1A5 to increase the glutamine uptake, and the enzymes GLS1 / 2 which convert glutamine to glutamate [63].